Multiple studies have found a positive correlation between IL-10 levels and poor prognosis in various cancers, including melanoma, lung cancer, and T/NK-cell lymphomas (Boulland et al., 1998; Boyano et al., 2000; Li et al., 2014). Here, IL10 is linked to lung cancer.